Hong Kong Declares CBD a Dangerous Drug

Feb.01.2023
Hong Kong Declares CBD a Dangerous Drug
CBD is now a controlled substance in Hong Kong, with potential life imprisonment and heavy fines for offenders.

As of February 1st, CBD has been officially classified as a dangerous drug and is now subject to regulation under Hong Kong's Dangerous Drugs Ordinance (Chapter 134).


Following this, the Hong Kong police force and customs department will make every effort to crackdown on drug-related offenses involving CBD.


After the law takes effect, those trafficking and illegally manufacturing CBD and its products can be sentenced to life imprisonment and fined up to HKD 5 million (approximately RMB 4.3 million). Those who possess or use the substance in violation of the Dangerous Drugs Ordinance can be sentenced to seven years in prison and fined up to HKD 1 million (approximately RMB 860,000).


The Hong Kong government previously arranged for a disposal collection of items containing CBD, allowing citizens to voluntarily dispose of them, and assisting those in need with large-scale disposals. As of January 29th, the government has collected approximately 77,400 items containing CBD, mostly skincare products, oral oils, and health supplements.


Reference:


Hong Kong is planning to completely ban the sale of CBD products by the end of 2022.


Starting tomorrow, regulations regarding cannabidiol (CBD) will be enforced and those who violate them will face legal consequences.


Hong Kong plans to ban the sale of CBD products entirely by the end of 2022.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | HQD Launches 2-in-1 Switchable Flavor Vape with 35,000 Puffs and 10 Flavor Combos
Product | HQD Launches 2-in-1 Switchable Flavor Vape with 35,000 Puffs and 10 Flavor Combos
E-cigarette brand HQD has launched the GLOW AIR 35K, featuring a 2-in-1 design with a 2+20ml e-liquid setup and 10 flavor combinations. The product is now listed on the brand’s official website but is not yet available for online purchase.
May.13 by 2FIRSTS.ai
Global e-cigarette expo in Dubai showcases new products and trends.
Global e-cigarette expo in Dubai showcases new products and trends.
World Vape Show Dubai 2025, held from June 18-20, showcased innovative e-cigarette products at Dubai World Trade Center.
Jun.20 by 2FIRSTS.ai
Papua New Guinea Announces Total Ban on E-Cigarettes, Violators Face Fines of Up to $48,000
Papua New Guinea Announces Total Ban on E-Cigarettes, Violators Face Fines of Up to $48,000
The Papua New Guinea government has announced a total ban on the sale, import, and use of e-cigarette products. The ban will take effect within a week of its publication in the National Gazette. Under the Tobacco Control Act 2016, individuals found in violation may be fined up to 10,000 kina (approximately USD 2,400), while businesses could face fines of up to 200,000 kina (around USD 48,000).
May.15 by 2FIRSTS.ai
U.S. Compliance Specialist: Why an STN Falls Short for NGPs Entering the U.S. Market
U.S. Compliance Specialist: Why an STN Falls Short for NGPs Entering the U.S. Market
Many manufacturers misunderstand the role of an STN in the U.S. regulatory framework. This article explains why only a fully approved PMTA ensures legal market access—and why stopping at the STN stage could carry significant risks.
May.09
Japan Tobacco Q1 2025 Results: Revenue Up 11.7% to $5.8 Billion, Heated Tobacco Sales Rise 28%
Japan Tobacco Q1 2025 Results: Revenue Up 11.7% to $5.8 Billion, Heated Tobacco Sales Rise 28%
Japan Tobacco Inc. (JT) reported first-quarter revenue of ¥827 billion ($5.8 billion), up 11.7% year-on-year, driven by double-digit growth in reduced-risk products (RRP). The company announced plans to divest its pharmaceutical business, with the transaction expected to close in the second half of the year. Management reiterated its medium- to long-term strategic goal of achieving approximately 15% market share in key heated tobacco markets by the end of 2028.
May.07 by 2FIRSTS.ai
Japan Tobacco International Acquires UK’s Largest Independent Vape Firm, Whose Products Reach Over 80 Countries
Japan Tobacco International Acquires UK’s Largest Independent Vape Firm, Whose Products Reach Over 80 Countries
Japan Tobacco International (JTI) has recently acquired a controlling stake (over 50% but less than 75%) in Flavour Warehouse, the UK’s largest independent vape company, to strengthen its position in the reduced-risk product segment. Flavour Warehouse is one of Europe’s leading e-liquid manufacturers, with products sold in over 80 countries worldwide.
May.14 by 2FIRSTS.ai